← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2013Last known activity
Oct 1, 2016
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT02929888Reponsible party - principal investigatorPhase 2/Phase 3Oct 1, 2016
- NCT02929888Lead sponsorPhase 2/Phase 3Oct 1, 2016
- NCT02698618Lead sponsorPhase 4Mar 1, 2016
- NCT02243137Sponsor investigatorPhase 1May 1, 2013
- NCT02243137Lead sponsorPhase 1May 1, 2013
Details
- Last known activity
- Oct 1, 2016